77 results
S-8
EX-99.1
VANI
Vivani Medical Inc
2 Sep 22
Registration of securities for employees
5:00pm
and Stock Appreciation Rights may be exercised;
(vii) at any time, to alter any performance goals upon which grant, vesting, exercise, settlement … or nonforfeitable as of the effective time of the Sale Event, and all Awards with conditions and restrictions relating to the attainment of performance goals may
8-K
EX-99.1
VANI
Vivani Medical Inc
25 Jun 19
Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study
4:00pm
improvements in their ability to perform everyday tasks and successfully meet the study’s functional vision endpoint goals. It is also encouraging to see … objectives or goals, or that are not otherwise historical facts, are forward-looking statements. While management has based any forward-looking statements
8-K
EX-99.1
VANI
Vivani Medical Inc
6 Nov 18
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
5:03pm
, such as stated objectives or goals, or that are not otherwise historical facts, are forward-looking statements. While management has based any forward-looking
8-K
VANI
Vivani Medical Inc
29 Sep 20
Departure of Directors or Certain Officers
6:01am
salary. The bonuses will be based on performance standards and goals to be met by Mr. Randolph in amounts and on terms established by the Company’s
8-K
EX-10.1
VANI
Vivani Medical Inc
29 Sep 20
Departure of Directors or Certain Officers
6:01am
be eligible for an annual cash bonus of up to 30.0%, or a portion thereof, depending on whether Company goals are met at December 31, 2020 per Second Sight’s
8-K
EX-99.1
x24f79zb
30 Mar 20
Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO
3:52pm
8-K
EX-99.1
4htgp5eo0
5 May 20
Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock
1:16pm
8-K
EX-99.1
90eajvph71jrb p4
25 Sep 20
Second Sight Medical Products Inc. Announces Resumption of Its Early Feasibility Study of the Orion® Cortical Visual Prosthesis at UCLA
6:02am
8-K
EX-99.1
362tly
28 Apr 20
Second Sight Medical Products Provides Business Update
8:15am
8-K
EX-99.1
j3bfg
14 Dec 18
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
8:15am
8-K
EX-99.1
xubnbg9j7e quu
12 Mar 20
Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO
4:35pm
8-K
EX-99.1
sz3gl
22 Feb 19
Second Sight Medical Products, Inc. Announces Completion of
8:25am
8-K
EX-99.1
6l3ay68h
1 May 20
Second Sight Medical Products Announces Pricing of Public Offering of Common Stock
6:02am
8-K
EX-99.1
ma84ix90mn lcx
15 May 19
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
4:31pm
8-K
EX-99.1
g2i1b
7 Jan 19
Second Sight Reports Fourth Quarter 2018 Business Update
8:16am
8-K
EX-99.1
6amli
16 Aug 18
Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
8:06am
8-K
EX-99.1
gchgvti30wp9u s4q9d
11 Apr 19
Regulation FD Disclosure
8:16am
8-K
EX-99.1
bzz9t6vpt9fsrc3
8 May 18
Second Sight Completes $10 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
6:12am
8-K
EX-99.1
v2e48v0p8j s3k69
22 Oct 18
Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
9:22am
8-K
EX-99.9
6qp3d
9 Jan 19
Entry into a Material Definitive Agreement
8:39am